A drug under trial reduces risk of heart attack, stroke
Wednesday, 2 April 2025 An experimental drug by Eli Lilly, called lepodisiran, has shown promising results in lowering Lp(a) levels, a particle linked to heart attack and stroke risk, by 94% with just one injection. While more studies are needed to confirm its effectiveness, this breakthrough could be significant for those with elevated Lp(a) levels, as existing treatments are limited.
Former glamour model Katie Price has admitted she's "heartbroken" over her son Harvey's weight issues and she's worried he's now at risk of suffering a heart attack.
Did you know that in a study of those who experienced a heart attack at age 50 or younger, half were not previously seen as high risk? Renowned cardiologist and Bayer spokesperson, Dr. Jayne Morgan,..